Revolution Medicines (RVMD) Gains from Investment Securities (2023 - 2026)
Revolution Medicines (RVMD) posted Gains from Investment Securities of $151.0 million for Q2 2026, up 856.62% on a QoQ basis from $15.8 million in Q1 2026, and up 3199.06% year-over-year from $4.6 million in Q2 2025.
Powered by 
Analysis
Revolution Medicines (RVMD) Gains from Investment Securities (2023 - 2026) Analysis & Trends
Revolution Medicines has reported Gains from Investment Securities for 4 years, with the latest figure at $151.0 million in Q2 2026.
- On a quarterly basis, Gains from Investment Securities rose 3199.06% year-over-year to $151.0 million in Q2 2026; TTM through Jun 2026 was $180.0 million, a 4862.46% increase from a year earlier, with the FY2025 full-year figure at $15.4 million, up 455.26% from the prior year.
- Gains from Investment Securities was $151.0 million for Q2 2026 at Revolution Medicines, up from $15.8 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $151.0 million in Q2 2026, with the low at -$3.9 million in Q1 2024.
- Average Gains from Investment Securities over 4 years is $16.2 million, with a median of $592000.0 recorded in 2025.
- The largest YoY upside for Gains from Investment Securities was 5639.55% in 2025 against a maximum downside of 53.35% in 2025.
- Over 4 years, Gains from Investment Securities stood at $115000.0 in 2023, then jumped by 91.3% to $220000.0 in 2024, then jumped by 5639.55% to $12.6 million in 2025, then jumped by 1096.1% to $151.0 million in 2026.
- The last three Gains from Investment Securities figures came in at $151.0 million (Q2 2026), $15.8 million (Q1 2026), and $12.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn |
| 10 | Revolution Medicines | 40.86 Bn | 40.86 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 151.03 Mn |
| Mar 31, 2026 | 15.79 Mn |
| Dec 31, 2025 | 12.63 Mn |
| Sep 30, 2025 | 592,000.00 |
| Jun 30, 2025 | 4.58 Mn |
| Mar 31, 2025 | -2.44 Mn |
| Dec 31, 2024 | 220,000.00 |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | -1.91 Mn |
| Mar 31, 2024 | -3.91 Mn |
| Dec 31, 2023 | 115,000.00 |
API Access
Revolution Medicines Gains from Investment Securities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-investment-securities", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();